Loading…
Integra LifeSciences Holdings Corporation is projected to rise to $20.12 by 2027, a +21% move from its current price of $16.65. IART is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $16.10 | $16.65 | $17.22 | 0.00% |
| Aug 3 | $15.88 | $16.65 | $17.45 | +0.01% |
| Aug 4 | $15.72 | $16.65 | $17.64 | +0.01% |
| Aug 5 | $15.58 | $16.65 | $17.80 | +0.01% |
| Aug 6 | $15.46 | $16.65 | $17.94 | +0.01% |
| Aug 7 | $15.35 | $16.65 | $18.07 | +0.02% |
| Aug 8 | $15.25 | $16.65 | $18.19 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.25 | $16.65 | $18.19 | +0.02% |
| Week 2 | $14.70 | $16.66 | $18.87 | +0.04% |
| Week 3 | $14.30 | $16.66 | $19.41 | +0.06% |
| Week 4 | $13.97 | $16.66 | $19.88 | +0.08% |
| Week 5 | $13.68 | $16.67 | $20.30 | +0.09% |
| Week 6 | $13.43 | $16.67 | $20.69 | +0.11% |
| Week 7 | $13.20 | $16.67 | $21.06 | +0.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments and products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments and offers its products directly through sales forces and other channels to hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally.
Integra LifeSciences was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Integra LifeSciences Holdings Corporation (IART) operates in the Healthcare sector. The current price is $16.49, with a market cap of $1.28B and a rank of 2358. The stock sits in a broader price environment that the forecast envisions as gradually rising in coming years, beginning with a neutral outlook for 2026 and turning bullish in subsequent years as averages and potential returns increase.
Forecasts show a path of rising averages from 2027 onward, with 2027 average $19.94, 2028 average $26.38, 2029 average $32.69, and 2030 average $41.54, accompanied by corresponding ROIs of 20.9%, 60%, 98.3%, and 151.9% respectively. The longer-horizon outlook remains bullish with higher average prices projected for 2031–2050 (e.g., 2050 average $322.88 with a 1858% ROI).
A major floor 45.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.0% away) — a key level to hold.
The nearest ceiling, 19.2% above — a clean break opens room to run.
A major ceiling 26.3% above — clearing it would confirm fresh momentum.
Key IART support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IART market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.91 | Sell | $17.56 | Sell |
| MA 10 | $18.46 | Sell | $18.08 | Sell |
| MA 20 | $18.48 | Sell | $18.23 | Sell |
| MA 50 | $17.60 | Sell | $17.19 | Sell |
| MA 100 | $14.21 | Buy | $15.57 | Buy |
| MA 200 | $13.32 | Buy | $14.72 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.97 | Neutral |
| Stoch RSI (14) | 6.77 | Buy |
| CCI (20) | -155.41 | Sell |
| Williams %R (14) | -95.24 | Info |
| MACD (12,26,9) | -0.36 | Sell |
| ROC (12) | -11.34 | Sell |
| Bollinger %B (20,2) | 0.04 | Neutral |
| Stochastic %K (14) | 4.76 | Buy |
| TRIX (15) | 0.33 | Buy |
| Awesome (5,34) | -0.32 | Sell |
| Ultimate (7,14,28) | 36.78 | Neutral |
| Momentum (10) | -2.60 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 16.75 | Sell |
| ADX (14) | 22.72 | Sell |
| ATR (14) | 0.61 | Info |
30-day technical picture: Sentiment is BULLISH with RSI(14) at 40. The 50-day simple moving average is $17.49 and the 200-day simple moving average is $13.29.
The current price level shows support at $16.49 and resistance at $19.85. The 30-day range runs from $13.13 to $20.71, and annualized volatility is high at 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.90 | $16.65 | $22.92 | 0% | Neutral | |
| $15.73 | $20.12 | $27.41 | +21% | Bullish | |
| $19.95 | $26.44 | $37.66 | +59% | Bullish | |
| $23.98 | $32.73 | $48.26 | +97% | Bullish | |
| $29.52 | $41.36 | $62.75 | +148% | Bullish | |
| $35.69 | $51.21 | $79.66 | +208% | Bullish | |
| $35.53 | $52.13 | $82.91 | +213% | Bullish | |
| $37.02 | $55.47 | $90.02 | +233% | Bullish | |
| $41.48 | $63.40 | $104.80 | +281% | Bullish | |
| $48.75 | $75.95 | $127.71 | +356% | Bullish | |
| $70.54 | $120.04 | $216.70 | +621% | Bullish | |
| $159.76 | $317.85 | $635.62 | +18.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.90 | $16.65 | $20.47 | +0.00% |
| September 2026 | $13.84 | $16.48 | $20.26 | -1.02% |
| October 2026 | $13.90 | $16.69 | $20.78 | +1.28% |
| November 2026 | $14.62 | $17.67 | $22.23 | +5.88% |
| December 2026 | $14.84 | $18.05 | $22.92 | +2.15% |
Click any year to see its month-by-month IART forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IART price prediction for 2026 points to an average of $16.65 (low $8.90, high $22.92) — a potential gain of 0% on today's $16.65. A consolidation phase looks the most probable path here.
In 2027, IART is projected to trade between $15.73 and $27.41, averaging $20.12 — a potential gain of +21% from today's $16.65. That is up +21% on the projected 2026 average. Momentum favours further upside here.
Integra LifeSciences Holdings Corporation's 2028 outlook centres on $26.44, within a $19.95 to $37.66 range. That is up +31% on the projected 2027 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, IART could reach as high as $48.26, with a base case around $32.73 and support toward $23.98 — roughly +97% from $16.65. Momentum favours further upside here.
Expect IART to range from $29.52 to $62.75 through 2030. The $41.36 average target implies a +148% move from current prices. That is up +26% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The IART price prediction for 2031 points to an average of $51.21 (low $35.69, high $79.66) — a potential gain of +208% on today's $16.65. Momentum favours further upside here.
In 2032, IART is projected to trade between $35.53 and $82.91, averaging $52.13 — a potential gain of +213% from today's $16.65. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Integra LifeSciences Holdings Corporation's 2033 outlook centres on $55.47, within a $37.02 to $90.02 range. That is up +6% on the projected 2032 average. That marks a +233% change versus current levels. Momentum favours further upside here.
By 2034, IART could reach as high as $104.80, with a base case around $63.40 and support toward $41.48 — roughly +281% from $16.65. Buyers look set to stay in control over this stretch.
Expect IART to range from $48.75 to $127.71 through 2035. The $75.95 average target implies a +356% move from current prices. That is up +20% on the projected 2034 average. Momentum favours further upside here.
The IART price prediction for 2040 points to an average of $120.04 (low $70.54, high $216.70) — a potential gain of +621% on today's $16.65. Buyers look set to stay in control over this stretch.
In 2050, IART is projected to trade between $159.76 and $635.62, averaging $317.85 — a potential gain of +18.1x from today's $16.65. That is up +165% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in IART today (≈ 60.06006 IART) could be worth
$19,090.22
+$18,090.22 (+1809%) by 2050 · US Dollar
Based on the average projected IART price of $317.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IARTwould be worth at today's price.
$1,000 invested in IART on Jul 31, 2025 (≈ 76.103499 IART) would be worth
$1,267.12
+$267.12 (+26.7%) today · 1.27× · US Dollar
Based on a IART entry price of $13.14 vs. today's $16.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $19.79 | $841.33 | -15.9% |
| 1 month ago | $17.89 | $930.69 | -6.9% |
| 3 months ago | $10.95 | $1,520.55 | +52.1% |
| 6 months ago | $11.16 | $1,491.94 | +49.2% |
| 1 year ago | $13.14 | $1,267.12 | +26.7% |
| All time (5.0y) ago | $70.99 | $234.54 | -76.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IART forecast.
Our base-case forecast reaches $33.00 around 2030.
Implied market cap at $33.00: $2.57B
The multi-year forecast indicates bullish sentiment from 2027 onward, with a clear trajectory of rising averages and very large potential ROIs. In 2030 the average price is projected at $41.54 with an ROI of 151.9% and a min/max of $29.40/$63.59. By 2040 the average is $120.98 with a 633.6% ROI and a min/max of $69.82/$221.32.
By 2050 the average is $322.88 with an ROI of 1858% and a min/max of $157.87/$655.77. The 2026 forecast is neutral, with an average of $16.49 and a range of $8.90 to $22.80.
These numbers represent estimates, not guarantees, and the outlook acknowledges uncertainty and the possibility of volatility given the projected growth path and the wide annualized volatility noted earlier.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $41.54 with an ROI of 151.9%. The min and max are $29.40 and $63.59 respectively.
Forecasts indicate bullish sentiment from 2027 onward, with rising averages and sizable ROIs (e.g., 2027 avg $19.94; 2028 avg $26.38; 2029 avg $32.69; 2030 avg $41.54). The 2026 outlook is neutral, and outcomes are not guaranteed.
Yes. The 2030 forecast lists a max of $63.59, which exceeds $62.
The 2040 forecast shows an average price of $120.98 with an ROI of 633.6%.
The figures are estimates and not guarantees. The 2026 outlook is neutral while the longer-horizon path is bullish, and the forecast includes a high annualized volatility of 70%, reflecting potential sharp fluctuations.
Integra LifeSciences Holdings Corporation Community Discussion
0Share your Integra LifeSciences Holdings Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.